questionsmedicales.fr
Comportement et mécanismes comportementaux
Comportement
Comportement impulsif
Comportement compulsif
Comportement toxicomaniaque
Comportement toxicomaniaque : Questions médicales fréquentes
Termes MeSH sélectionnés :
Avoidant Restrictive Food Intake Disorder
Diagnostic
5
Addiction
Diagnostic médical
Tests psychologiques
Addiction
Professionnels de santé
Addiction
Signes cliniques
Addiction
Évaluation clinique
Addiction
Symptômes
5
Symptômes physiques
Addiction
Substances psychoactives
Addiction
Prévention
5
Soutien familial
Addiction
Activités de loisirs
Addiction
Campagnes de sensibilisation
Addiction
Traitements
5
Thérapie comportementale
Traitement de l'addiction
Thérapie cognitive
Addiction
Soutien de groupe
Addiction
Durée du traitement
Addiction
Complications
5
Maladies physiques
Addiction
Relations interpersonnelles
Addiction
Troubles psychologiques
Addiction
Facteurs de risque
5
Facteurs de risque
Addiction
Troubles mentaux
Addiction
Environnement social
Addiction
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Comportement toxicomaniaque : Questions médicales les plus fréquentes",
"headline": "Comportement toxicomaniaque : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Comportement toxicomaniaque : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-24",
"dateModified": "2025-02-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Comportement toxicomaniaque"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Comportement compulsif",
"url": "https://questionsmedicales.fr/mesh/D003192",
"about": {
"@type": "MedicalCondition",
"name": "Comportement compulsif",
"code": {
"@type": "MedicalCode",
"code": "D003192",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F01.145.527.100"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Addiction à la technologie",
"alternateName": "Technology Addiction",
"url": "https://questionsmedicales.fr/mesh/D000088942",
"about": {
"@type": "MedicalCondition",
"name": "Addiction à la technologie",
"code": {
"@type": "MedicalCode",
"code": "D000088942",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F01.145.527.100.120.875"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dépendance à Internet",
"alternateName": "Internet Addiction Disorder",
"url": "https://questionsmedicales.fr/mesh/D000082424",
"about": {
"@type": "MedicalCondition",
"name": "Dépendance à Internet",
"code": {
"@type": "MedicalCode",
"code": "D000082424",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F01.145.527.100.120.875.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Comportement toxicomaniaque",
"alternateName": "Behavior, Addictive",
"code": {
"@type": "MedicalCode",
"code": "D016739",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Astrid Müller",
"url": "https://questionsmedicales.fr/author/Astrid%20M%C3%BCller",
"affiliation": {
"@type": "Organization",
"name": "Abteilung für Psychosomatische Medizin und Psychotherapie, Hannover Medical School, Hannover, Deutschland."
}
},
{
"@type": "Person",
"name": "Matthias Brand",
"url": "https://questionsmedicales.fr/author/Matthias%20Brand",
"affiliation": {
"@type": "Organization",
"name": "General Psychology: Cognition and Center for Behavioral Addiction Research (CeBAR), University of Duisburg-Essen, Germany; Erwin L. Hahn Institute for Magnetic Resonance Imaging, Essen, Germany. Electronic address: matthias.brand@uni-due.de."
}
},
{
"@type": "Person",
"name": "Elisa Wegmann",
"url": "https://questionsmedicales.fr/author/Elisa%20Wegmann",
"affiliation": {
"@type": "Organization",
"name": "General Psychology: Cognition and Center for Behavioral Addiction Research (CeBAR), University of Duisburg-Essen, Germany."
}
},
{
"@type": "Person",
"name": "Mark D Griffiths",
"url": "https://questionsmedicales.fr/author/Mark%20D%20Griffiths",
"affiliation": {
"@type": "Organization",
"name": "International Gaming Research Unit, Psychology Department, Nottingham Trent University, Nottingham, UK."
}
},
{
"@type": "Person",
"name": "Yui Asaoka",
"url": "https://questionsmedicales.fr/author/Yui%20Asaoka",
"affiliation": {
"@type": "Organization",
"name": "Primate Research Institute, Kyoto University, Inuyama, Aichi, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Assessment and Treatment of Avoidant/Restrictive Food Intake Disorder.",
"datePublished": "2023-01-14",
"url": "https://questionsmedicales.fr/article/36640211",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11920-022-01404-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Avoidant restrictive food intake disorder and suicidal ideation.",
"datePublished": "2022-10-23",
"url": "https://questionsmedicales.fr/article/37732866",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.psychres.2022.114925"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Intersection of Disorders of Gut-Brain Interaction With Avoidant/Restrictive Food Intake Disorder.",
"datePublished": "2023-08-01",
"url": "https://questionsmedicales.fr/article/37079861",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MCG.0000000000001853"
}
},
{
"@type": "ScholarlyArticle",
"name": "Avoidant-restrictive food intake disorder in a male patient with Goldenhar syndrome.",
"datePublished": "2022-10-30",
"url": "https://questionsmedicales.fr/article/36310338",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40519-022-01497-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Avoidant restrictive food intake disorder and pediatric feeding disorder: the pediatric gastroenterology perspective.",
"datePublished": "2023-07-17",
"url": "https://questionsmedicales.fr/article/37461875",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MOP.0000000000001267"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Comportement et mécanismes comportementaux",
"item": "https://questionsmedicales.fr/mesh/D001520"
},
{
"@type": "ListItem",
"position": 3,
"name": "Comportement",
"item": "https://questionsmedicales.fr/mesh/D001519"
},
{
"@type": "ListItem",
"position": 4,
"name": "Comportement impulsif",
"item": "https://questionsmedicales.fr/mesh/D007175"
},
{
"@type": "ListItem",
"position": 5,
"name": "Comportement compulsif",
"item": "https://questionsmedicales.fr/mesh/D003192"
},
{
"@type": "ListItem",
"position": 6,
"name": "Comportement toxicomaniaque",
"item": "https://questionsmedicales.fr/mesh/D016739"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Comportement toxicomaniaque - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Comportement toxicomaniaque",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Comportement toxicomaniaque",
"description": "Comment diagnostiquer une addiction ?\nQuels tests sont utilisés pour l'addiction ?\nQui peut diagnostiquer une addiction ?\nQuels signes indiquent une addiction ?\nQuelle est la durée pour un diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D016739?mesh_terms=Avoidant+Restrictive+Food+Intake+Disorder#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Comportement toxicomaniaque",
"description": "Quels sont les symptômes d'une addiction ?\nComment l'addiction affecte-t-elle le comportement ?\nY a-t-il des symptômes physiques d'addiction ?\nLes symptômes varient-ils selon la substance ?\nComment reconnaître une rechute ?",
"url": "https://questionsmedicales.fr/mesh/D016739?mesh_terms=Avoidant+Restrictive+Food+Intake+Disorder#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Comportement toxicomaniaque",
"description": "Comment prévenir l'addiction ?\nLes programmes scolaires aident-ils à prévenir l'addiction ?\nLe soutien familial joue-t-il un rôle ?\nLes activités de loisirs aident-elles à prévenir l'addiction ?\nLes campagnes de sensibilisation sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D016739?mesh_terms=Avoidant+Restrictive+Food+Intake+Disorder#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Comportement toxicomaniaque",
"description": "Quels traitements sont disponibles pour l'addiction ?\nLa thérapie cognitive est-elle efficace ?\nQuels médicaments sont utilisés pour traiter l'addiction ?\nLe soutien de groupe est-il bénéfique ?\nCombien de temps dure un traitement d'addiction ?",
"url": "https://questionsmedicales.fr/mesh/D016739?mesh_terms=Avoidant+Restrictive+Food+Intake+Disorder#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Comportement toxicomaniaque",
"description": "Quelles complications peuvent survenir avec l'addiction ?\nL'addiction peut-elle entraîner des maladies physiques ?\nComment l'addiction affecte-t-elle les relations ?\nY a-t-il des risques de suicide liés à l'addiction ?\nLes complications psychologiques sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D016739?mesh_terms=Avoidant+Restrictive+Food+Intake+Disorder#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Comportement toxicomaniaque",
"description": "Quels sont les facteurs de risque d'addiction ?\nL'âge influence-t-il le risque d'addiction ?\nLe stress est-il un facteur de risque ?\nLes troubles mentaux augmentent-ils le risque d'addiction ?\nL'environnement social joue-t-il un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D016739?mesh_terms=Avoidant+Restrictive+Food+Intake+Disorder#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une addiction ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des critères cliniques, des antécédents et des évaluations psychologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'addiction ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des questionnaires standardisés et des évaluations cliniques sont utilisés pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Qui peut diagnostiquer une addiction ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un professionnel de santé, comme un psychiatre ou un psychologue, peut poser le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une addiction ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent la perte de contrôle, le besoin compulsif et des conséquences négatives."
}
},
{
"@type": "Question",
"name": "Quelle est la durée pour un diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic peut prendre plusieurs séances pour évaluer les comportements et les impacts."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une addiction ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'irritabilité, l'anxiété, et des changements d'humeur fréquents."
}
},
{
"@type": "Question",
"name": "Comment l'addiction affecte-t-elle le comportement ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des comportements impulsifs, des conflits interpersonnels et des problèmes de santé."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes physiques d'addiction ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes physiques comme des tremblements, des nausées et des douleurs peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon la substance ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon la substance utilisée, comme l'alcool ou les opioïdes."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une rechute ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une rechute se manifeste par le retour à l'usage compulsif après une période d'abstinence."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'addiction ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'éducation, la sensibilisation et le soutien social dès le jeune âge."
}
},
{
"@type": "Question",
"name": "Les programmes scolaires aident-ils à prévenir l'addiction ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les programmes éducatifs sur les risques des substances peuvent réduire l'usage précoce."
}
},
{
"@type": "Question",
"name": "Le soutien familial joue-t-il un rôle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un soutien familial solide peut diminuer le risque d'addiction chez les jeunes."
}
},
{
"@type": "Question",
"name": "Les activités de loisirs aident-elles à prévenir l'addiction ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les activités de loisirs saines peuvent offrir des alternatives à l'usage de substances."
}
},
{
"@type": "Question",
"name": "Les campagnes de sensibilisation sont-elles efficaces ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles augmentent la conscience des dangers et peuvent réduire l'usage de substances."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour l'addiction ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie comportementale, les médicaments et le soutien de groupe."
}
},
{
"@type": "Question",
"name": "La thérapie cognitive est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie cognitive aide à modifier les pensées et comportements liés à l'addiction."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour traiter l'addiction ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les agonistes opioïdes et les antidépresseurs peuvent être prescrits."
}
},
{
"@type": "Question",
"name": "Le soutien de groupe est-il bénéfique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le soutien de groupe offre un environnement de partage et de motivation pour la sobriété."
}
},
{
"@type": "Question",
"name": "Combien de temps dure un traitement d'addiction ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie, mais peut durer plusieurs mois à plusieurs années selon les besoins."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'addiction ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des problèmes de santé mentale, des maladies physiques et des conflits sociaux."
}
},
{
"@type": "Question",
"name": "L'addiction peut-elle entraîner des maladies physiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'addiction peut causer des maladies comme des troubles hépatiques, cardiaques ou pulmonaires."
}
},
{
"@type": "Question",
"name": "Comment l'addiction affecte-t-elle les relations ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des conflits, des ruptures et un isolement social significatif."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de suicide liés à l'addiction ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes dépendantes présentent un risque accru de comportements suicidaires."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'addiction est souvent associée à des troubles comme la dépression et l'anxiété."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'addiction ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des troubles mentaux et l'environnement social."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'addiction ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes sont plus vulnérables en raison de la recherche de sensations et de l'immaturité."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut augmenter le risque d'usage de substances comme mécanisme d'adaptation."
}
},
{
"@type": "Question",
"name": "Les troubles mentaux augmentent-ils le risque d'addiction ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec des troubles mentaux sont plus susceptibles de développer une addiction."
}
},
{
"@type": "Question",
"name": "L'environnement social joue-t-il un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un environnement social favorable à l'usage de substances augmente le risque d'addiction."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/02/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Abteilung für Psychosomatische Medizin und Psychotherapie, Hannover Medical School, Hannover, Deutschland.
Publications dans "Comportement toxicomaniaque" :
3 publications dans cette catégorie
Affiliations :
General Psychology: Cognition and Center for Behavioral Addiction Research (CeBAR), University of Duisburg-Essen, Germany; Erwin L. Hahn Institute for Magnetic Resonance Imaging, Essen, Germany. Electronic address: matthias.brand@uni-due.de.
Publications dans "Comportement toxicomaniaque" :
3 publications dans cette catégorie
Affiliations :
General Psychology: Cognition and Center for Behavioral Addiction Research (CeBAR), University of Duisburg-Essen, Germany.
Publications dans "Comportement toxicomaniaque" :
3 publications dans cette catégorie
Affiliations :
International Gaming Research Unit, Psychology Department, Nottingham Trent University, Nottingham, UK.
Publications dans "Comportement toxicomaniaque" :
3 publications dans cette catégorie
Affiliations :
Primate Research Institute, Kyoto University, Inuyama, Aichi, Japan.
Publications dans "Comportement toxicomaniaque" :
3 publications dans cette catégorie
Affiliations :
Kyowa Hospital, Obu, Aichi, Japan.
Publications dans "Comportement toxicomaniaque" :
3 publications dans cette catégorie
Affiliations :
Kyowa Hospital, Obu, Aichi, Japan.
Publications dans "Comportement toxicomaniaque" :
3 publications dans cette catégorie
Affiliations :
Kyowa Hospital, Obu, Aichi, Japan.
Publications dans "Comportement toxicomaniaque" :
3 publications dans cette catégorie
Affiliations :
Primate Research Institute, Kyoto University, Inuyama, Aichi, Japan.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
Department of Preventive Medicine, University of Southern California, 2001 N Soto St., Los Angeles, CA 90032, USA.
Department of Psychology, University of Southern California, 3620 South McClintock Ave, Los Angeles, CA 90089, USA.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
Klinik für Psychosomatische Medizin und Psychotherapie, Universitätsmedizin Mainz, Mainz, Deutschland.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
Departments of Psychiatry, Neuroscience and Child Study, Yale University School of Medicine, New Haven, USA; Connecticut Council on Problem Gambling, Wethersfield, USA; Connecticut Mental Health Center, New Haven, USA.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
Department of Psychology, Bar-Ilan University, Ramat-Gan 52900, Israel.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel; Leslie and Susan Gonda (Goldschmied) Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat-Gan 52900, Israel.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
Faculty of Education, Society and Culture, Beit-Berl College, Kfar-Saba 4490500, Israel.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
Department of Psychology, Bar-Ilan University, Ramat-Gan 52900, Israel; Leslie and Susan Gonda (Goldschmied) Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat-Gan 52900, Israel; Department of Psychiatry and Biobehavioral Sciences, 760 Westwood Plaza (C8-746), University of California, Los Angeles (UCLA), California 90095, United States. Electronic address: yurir@biu.ac.il.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
Psychology Research Laboratory, Ospedale San Giuseppe, IRCCS Istituto Auxologico Italiano, 28824 Verbania, Italy.
Department of Psychology, Catholic University of Milan, 20123 Milan, Italy.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, 08907 Barcelona, Spain.
CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, 08907 Barcelona, Spain.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Psychobiology and Methodology, Autonomous University of Barcelona, 08193 Barcelona, Spain.
Publications dans "Comportement toxicomaniaque" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, 08907 Barcelona, Spain.
CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, 08907 Barcelona, Spain.
Publications dans "Comportement toxicomaniaque" :
To review the literature pertaining to the assessment and treatment of avoidant/restrictive food intake disorder (ARFID) ten years following its introduction to DSM-5....
Several structured clinical interviews for assessing ARFID have been developed, each with its own strengths and limitations. There is no clear leading self-report measure for tracking treatment progre...
Most DSM-5 eating disorder diagnoses are associated with elevated suicide risk; however, little is known about the relationship between Avoidant/Restrictive Food Intake Disorder (ARFID) and suicidal i...
High rates of overlap exist between disorders of gut-brain interaction (DGBI) and eating disorders, for which common interventions conceptually conflict. There is particularly increasing recognition o...
Goldenhar syndrome (GS) is a rare congenital condition characterized by the underdevelopment of structures deriving from the first and second branchial arches. Clinical phenotype might encompass extra...
A 15-year-old boy with GS was referred to our outpatient clinic due to severe underweight (BMI of 12.7 kg/m...
The current report describes the first case of a young male with GS and ARFID. We suggest that ARFID may present itself as part of the spectrum of neuropsychiatric disorders associated with the syndro...
Level V, case report....
Avoidant/restrictive food intake disorder (ARFID) and pediatric feeding disorder (PFD) are the newest evolutions of frameworks for dysfunctional feeding and share overlapping features but maintain not...
Dysfunctional feeding, particularly withing the PFD definition, benefits from multidisciplinary care with equal attention to medical, nutritional, skill-based, and behavioral domains. Management requi...
ARFID and PFD not only share areas of overlap, but also differ, likely based on the origins of each framework. Ultimately, both frameworks describe dysfunctional feeding and require input from medical...
This scoping review identifies and describes psychological interventions for avoidant restrictive food intake disorder (ARFID) and summarizes how outcomes are measured across such interventions....
Five databases (Cochrane, Embase, Medline, PsycInfo, Web of Science) were searched up to December 22, 2022. Studies were included if they reported on psychological interventions for ARFID. Studies wer...
Fifty studies met inclusion criteria; almost half were single-case study designs (23 studies) and most studies reported on psychological interventions for children and adolescents with ARFID (42 studi...
This review provides a comprehensive summary of psychological interventions for ARFID since its introduction to the DSM-5. Across a range of psychological interventions and modalities for ARFID, there...
Avoidant restrictive food intake disorder (ARFID) is an eating disorder characterized by avoidance or restriction of food due to fear, sensory sensitivities, and/or a lack of interest in food. We revi...
There is considerable overlap between the features of avoidant-restrictive food intake disorder (ARFID) and autism. The purpose of this scoping review is to provide an overview of studies published on...
ARFID and autism are highly heritable conditions that often co-occur. In a large autism cohort, 21% of participants and 17% of their parents presented with avoidant-restrictive features. Of children d...
Individuals seeking specialist care for autism, eating disorders, or gender dysphoria should be screened for ARFID. More research is needed on how to support autistic adolescents and adults with featu...
The aim of the present study was to develop and validate the Avoidant/Restrictive Food Intake Disorder Questionnaire-Parents Report (ARFID-Q-PR), a new tool to diagnose ARFID, based on a report submit...
Avoidant/Restrictive Food Intake Disorder (ARFID) and food neophobia present significant challenges in pediatric healthcare, particularly among children with food allergies (FAs). These eating disorde...
Cognitive behavioral therapy for Avoidant Restrictive Food Intake Disorder (ARFID; CBT-AR) is an emerging treatment for ARFID. However, this treatment modality has yet to be examined among older adult...
G was a 71-year-old male who completed eight sessions of CBT-AR in a doctoral training clinic. ARFID symptom severity and comorbid eating pathology changes were examined pre- and post-treatment....
Posttreatment, G reported significant decreases in ARFID symptom severity and no longer met diagnostic criteria for ARFID. Furthermore, throughout treatment, G reported significant increases in his or...
This study provides proof of concept that CBT-AR is potentially effective for older adults and/or those presenting for treatment with feeding tubes. Validation of patient efforts and severity of ARFID...
Cognitive behavior therapy for ARFID (CBT-AR) is the leading treatment for this disorder; however, it has yet to be tested among older adults or those with feeding tubes. This single-patient case stud...